Cabozantinib |
Cabozantinib : ATP Competitive inhibitor of KDR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| KDR |
|
|
ATP Competitive
up to 10 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - c-Met 1.3 nM, Ret 4 nM, Kit 4.6 nM, Flt-1/3/4 12 nM/11.3 nM/6 nM, Tie2 14.3 nM, AXL 7 nM
Potency Assay Off-Target:
AlphaScreen Assay, Coupled Luciferase Assay, Radiometric Assay
Selectivity Assessment Description:
The inhibition profile of cabozantinib against a broad panel of 270 human kinases was determined ...
Potency Cellular
In Vitro
KDR
Mode of Action: ATP Competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1158/1535-7163.MCT-11-0264
In Vivo Validations
Chemical Information
| Molecular Formula | C28H24FN3O5 |
| SMILEs | COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC |
| InChI | InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) |
| Molecular weight | 501.17 Da |
| AlogP | 5.5408 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 61 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.